Table 3:
Heterogeneity in Heroin Effects
| Outcome: | Heroin Deaths per 100,000 |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| By Subgroup: | Age Group |
Gender |
Race |
Education |
|||||
| Ages 0–24 |
Ages 25–64 |
Ages 65+ |
Female |
Male |
White |
Non-White |
HS degree or less |
More than HS |
|
| (1) | (2) | (3) | (4) | (5) | (6) | (7) | (8) | (9) | |
| Initial OxyContin (3 Year Effect) | 1.159** (0.469) | 3.935** (1.752) | 0.191 (0.307) | 0.864* (0.459) | 4.164** (1.768) | 2.353** (0.953) | 1.812 (1.315) | 3.123 (2.105) | 2.411*** (0.864) |
| Mean of Dep. Variable (2008–09): | 0.490 | 1.670 | 0.064 | 0.375 | 1.769 | 1.193 | 0.810 | 1.980 | 0.595 |
Notes: Standard errors in parentheses adjusted for clustering at the state-level. State fixed effects and year fixed effects and the full set of covariates are included in all specifications. Each model also includes a linear trend interacted with initial nonmedical OxyContin misuse as well as a post-2011 indicator interacted with initial nonmedical OxyContin misuse. Finally, a separate post-2011 linear trend interacted with initial nonmedical OxyContin misuse is also included. We report the 3 year post-2011 effect of the initial OxyContin variable. Regressions are weighted by population. Years 2008–2013 are used. Columns 8 and 9 include only individuals ages 25+ to exclude those without completed education.
Significant at the 1% level
Significant at the 5% level
Significant at the 10% level.